Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis

<b>Background</b>: Treatment of inflammatory bowel diseases with biological therapies has significantly increased, with ever increasing numbers of patients receiving such treatment at the time of surgery. This study evaluates the perioperative safety of three commonly used biologics—Infl...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Alexandra-Eleftheria Menni, Georgios Tzikos, George Petrakis, Patroklos Goulas, Panagiotis V. Karathanasis, Stylianos Apostolidis
Format:	Article
Language:	English
Published:	MDPI AG 2025-09-01
Subjects:	IBDs INFL VDLZ USTK surgical complications meta-analysis
Online Access:	https://www.mdpi.com/1424-8247/18/10/1466